Biomarkers in Cardiorenal Syndrome

Cardiorenal syndrome is a clinical manifestation of the bidirectional interaction between the heart and kidney diseases. Over the last years, in patients with cardiovascular diseases, several biomarkers have been studied in order to better assess renal function as well as to identify patients prone...

Descripción completa

Detalles Bibliográficos
Autores principales: Goffredo, Giovanni, Barone, Roberta, Di Terlizzi, Vito, Correale, Michele, Brunetti, Natale Daniele, Iacoviello, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348334/
https://www.ncbi.nlm.nih.gov/pubmed/34362216
http://dx.doi.org/10.3390/jcm10153433
_version_ 1783735314040225792
author Goffredo, Giovanni
Barone, Roberta
Di Terlizzi, Vito
Correale, Michele
Brunetti, Natale Daniele
Iacoviello, Massimo
author_facet Goffredo, Giovanni
Barone, Roberta
Di Terlizzi, Vito
Correale, Michele
Brunetti, Natale Daniele
Iacoviello, Massimo
author_sort Goffredo, Giovanni
collection PubMed
description Cardiorenal syndrome is a clinical manifestation of the bidirectional interaction between the heart and kidney diseases. Over the last years, in patients with cardiovascular diseases, several biomarkers have been studied in order to better assess renal function as well as to identify patients prone to experiencing chronic or acute worsening of renal function. The aim of this review is to focus on the possible clinical usefulness of the most recent biomarkers in the setting of cardiorenal syndrome.
format Online
Article
Text
id pubmed-8348334
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83483342021-08-08 Biomarkers in Cardiorenal Syndrome Goffredo, Giovanni Barone, Roberta Di Terlizzi, Vito Correale, Michele Brunetti, Natale Daniele Iacoviello, Massimo J Clin Med Review Cardiorenal syndrome is a clinical manifestation of the bidirectional interaction between the heart and kidney diseases. Over the last years, in patients with cardiovascular diseases, several biomarkers have been studied in order to better assess renal function as well as to identify patients prone to experiencing chronic or acute worsening of renal function. The aim of this review is to focus on the possible clinical usefulness of the most recent biomarkers in the setting of cardiorenal syndrome. MDPI 2021-07-31 /pmc/articles/PMC8348334/ /pubmed/34362216 http://dx.doi.org/10.3390/jcm10153433 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Goffredo, Giovanni
Barone, Roberta
Di Terlizzi, Vito
Correale, Michele
Brunetti, Natale Daniele
Iacoviello, Massimo
Biomarkers in Cardiorenal Syndrome
title Biomarkers in Cardiorenal Syndrome
title_full Biomarkers in Cardiorenal Syndrome
title_fullStr Biomarkers in Cardiorenal Syndrome
title_full_unstemmed Biomarkers in Cardiorenal Syndrome
title_short Biomarkers in Cardiorenal Syndrome
title_sort biomarkers in cardiorenal syndrome
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348334/
https://www.ncbi.nlm.nih.gov/pubmed/34362216
http://dx.doi.org/10.3390/jcm10153433
work_keys_str_mv AT goffredogiovanni biomarkersincardiorenalsyndrome
AT baroneroberta biomarkersincardiorenalsyndrome
AT diterlizzivito biomarkersincardiorenalsyndrome
AT correalemichele biomarkersincardiorenalsyndrome
AT brunettinataledaniele biomarkersincardiorenalsyndrome
AT iacoviellomassimo biomarkersincardiorenalsyndrome

Ejemplares similares